Tesamorelin

Tesamorelin (TH9507)

Research-Grade GHRH Analogue
Tagline: GH Axis & Lipid Metabolism Research

Product Description

Tesamorelin (scientific designation TH9507) is a synthetic growth hormone–releasing hormone (GHRH) analogue that selectively stimulates the pituitary to secrete growth hormone (GH). It is widely studied for its ability to increase IGF-1 levels, reduce visceral adiposity, and improve metabolic profiles in research models.

Researchers use Tesamorelin in studies exploring GH/IGF-1 axis regulation, fat redistribution, body composition, and metabolic syndrome. Its high specificity for GHRH receptors and well-defined pharmacokinetics make it an excellent tool for endocrine and metabolic research.

For Laboratory and Scientific Research Use Only. Not for Human Consumption.

Why Researchers Choose Tesamorelin

• Highly Specific GHRH Analogue: Stimulates physiologic GH secretion without desensitizing pituitary receptors.

• Metabolic Relevance: Well-documented ability to reduce visceral fat and improve lipid profiles in studies.

• Extended Half-Life: Modified to resist degradation by DPP-IV, allowing once-daily dosing models.

• Purity & Reliability: ≥98% peptide purity ensures reproducible experimental results.

• Batch Verified: Identity and potency confirmed for every lot.

Important Note

For laboratory and scientific research only. Not for human consumption, veterinary use, or diagnostic purposes.